Nano-scale Quantum Dots for Retinal Stimulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing retinal stimulation devices are large, invasive, and cause light blockage or tissue damage, failing to effectively restore vision in damaged retinas due to conditions like retinitis pigmentosa and macular degeneration.
Innovation Solution
Implantation of nano-scale, light-sensitive quantum dot devices within the vitreous or sub-retinal area of the eye, which are biocompatible and adhere to native retinal cells, minimizing trauma and preserving neural networks.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If silicon-chip based photovoltaic devices are attached to the retina surface, then retinal stimulation is achieved, but light blockage occurs and retinal tissue may be damaged
Solution Approach 1:
The patent changes the size parameter from millimeter-scale silicon chips to nanometer-scale quantum dots, fundamentally altering the physical dimensions to eliminate light blockage while maintaining retinal stimulation capability. This parameter change resolves the contradiction between effective stimulation and harmful light blocking.
Solution Approach 2:
The patent replaces the mechanical attachment method (surgically implanting rigid silicon chips onto the retina) with a non-mechanical approach (injecting quantum dots that self-assemble and adhere to retinal cells). This substitution eliminates tissue damage while maintaining stimulation effectiveness.
2Reliability
If larger silicon-chip devices are implanted subretinally, then vision improvement is achieved, but oxygen transport is blocked and retinal tissue damage increases
Solution Approach 1:
By changing the size parameter from millimeter-scale devices to nanometer-scale quantum dots, the patent eliminates the physical obstruction of oxygen transport while maintaining the ability to improve vision. The nanoscale dimensions allow oxygen and nutrients to freely pass through the retinal layers.
3Object-affected harmful factors
If nano-scale quantum dot devices are injected into the vitreous or subretinal area, then light blockage is minimized and neural networks are preserved, but device effectiveness must be maintained at nanometer scale
Solution Approach 1:
The patent uses composite quantum dot structures with specific optical properties that enable effective retinal stimulation at nanometer scales. The quantum dots are engineered with precise bandgap energies to match retinal photoreceptor absorption spectra, maintaining stimulation effectiveness despite the size reduction.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The quantum dot devices significantly increase electrical retinal response to light, maintaining neural function and anatomy, and improving vision in damaged retinas with minimal light obstruction and tissue damage.
Implementation Method 1
silicon-chip based photovoltaic devices, which are attached to a portion of a retina, have been developed to stimulate rods and cones within the retina
Implementation Method 2
the quantum dot fluoresces in the presence of light
Data Source
AI summary
An improved method for stimulating electrical activity in an eye is provided. Provided is a technique for implanting small, nanometer-sized photoactive devices into an eye to improve electrical activity within an eye or mitigate degradation of electrical response in damaged eyes.